ANI Pharmaceuticals Announces Positive Six-Month Topline Data from the Phase 4 Open-Label, Single-Arm SYNCHRONICITY Trial Evaluating Fluocinolone Acetonide Intravitreal Implant in Patients with Chroni

Go back to ANI Pharmaceuticals Announces Positive Six-Month Topline Data from the Phase 4 Open-Label, Single-Arm SYNCHRONICITY Trial Evaluating Fluocinolone Acetonide Intravitreal Implant in Patients with Chroni
ANI PHARMACEUTICALS (NASDAQ: ANIP) Delayed: 78.85 +2.71 (3.56%)
Previous Close $76.14    52 Week High $70.92 
Open $75.50    52 Week Low $26.80 
Day High $79.43    P/E N/A 
Day Low $75.00    EPS $-0.96 
Volume 579,335       

ANI PHARMACEUTICALS (NASDAQ: ANIP) Delayed: 78.85 +2.71 (3.56%)
Previous Close $76.14    52 Week High $70.92 
Open $75.50    52 Week Low $26.80 
Day High $79.43    P/E N/A 
Day Low $75.00    EPS $-0.96 
Volume 579,335